Therapeutic Areas / All therapeutic areas
With over 55 products in 9 therapeutic areas, Alfasigma is a key player in the Italian pharmaceutical industry, boasting a portfolio ranging from prescription specialties and over-the-counter products all the way to nutraceuticals.
In Italy, it is a market leader for prescription drugs, boasting a presence in many primary care therapeutic areas (gastroenterology, vascular and diabetes, cardiology, orthopaedics and rheumatology, broncho-pneumology), as well as for well-known over-the-counter products such as Biochetase, Neo-Borocillin, Dicloreum and Yovis.
Worldwide, Alfasigma has products in the following therapeutic areas.
Gastrointestinal therapeutics are our specialty. Everyday we strive to give a concrete answer to functional gastro-intestinal disorders, gastro-oesophageal reflux disorder, hepatic encephalopathy and chronic liver disease (cirrhosis).
Vascular investigation is a company corporate mission. Venous diseases, lower extremity artery disease, diabetic microangiopathies and ventricular arrhythmia are the main pathologies in which we offer solutions.
In the metabolic area, our R&D has developed Carnitine, an amino acid derivative whose insufficiency can impair the metabolism of essential tissues, such as those of the heart and muscles.
Nutraceuticals & Medical foods
With our supplements, we are responding to the demand for a vast range of elements aimed at neural tissue well-being, recovery of muscle tone and combating physical and mental fatigue.